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T here is a strong tendency in current research on mammalian virus dis-eases to concentrate on virus activity at a cellular or subcellular level. 
This	trend	is	summarized	adequately	by	Enders	(1)	in	relation	to	viral	rep-
lication as follows: “The large and ever-increasing volume of published ex-
perimental work on viral replication strikingly reveals the central position 
of this phenomenon in contemporary virological research. There are good 
reasons, both biological and practical, underlying this intensive effort to un-
derstand, in detail, how a virus particle, without energy transforming ap-
paratus	of	 its	own,	manages	 to	utilize	 the	metabolic	 equipment	of	 the	 cell	
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to produce itself. At present, the specialists in this subject conceive of repli-
cation as mediated essentially by viral nucleic acids which assume the role 
of the cellular nucleic acids, thereby directing the synthesis of more nucleic 
acid of their own kind and providing the information necessary for the man-
ufacture	of	more	viral	protein.	The	enzymatic	complement	for	these	synthe-
ses	is	supplied	by	the	host	cell,	and	the	metabolic	sequences	are	not	consid-
ered to differ in essence from those involved in the manufacture of cellular 
nucleic acids and proteins.” 
Unquestionably,	basic	research	directed	toward	an	understanding	of	vi-
rus replication will play an important role in the eventual control of virus 
infections whether in man or his animals. Viruses in tissue culture systems 
may	behave	quite	differently	than	in	the	total	animal	host.	Essentially,	there	
are	no	restraining	influences	so	that	viruses	may	replicate	in	culture	at	will	
with severe damage to or destruction of the cells they attack. A parallel seem-
ingly exists between virus replication in a tissue culture system and replica-
tion in the total host with the experimental production of clinical or subclini-
cal disease. The virus which causes infectious bovine rhinotracheitis of cattle 
behaves in this manner. However, the virus which attacks a tissue culture 
system with all the traits of a pathogenic entity, including cytopathogenic ef-
fects on cells, yet lacks the capacity to cause measureable disease in the fully 
susceptible	host,	does	not	fit	 the	model.	Beran’s	swine	enterovirus	behaves	
in	 this	manner.	More	difficult	 to	 explain	 is	 the	virus	 that	produces	disease	
and	death	in	a	specific	host	yet	resists	adaptation	to	tissue	culture	systems,	in	
spite of every device the investigator may employ to encourage adaptation. 
This	category	is	 fulfilled	by	transmissible	gastroenteritis	virus	of	swine.	All	
three viruses will be discussed later in this chapter. 
Although much can be learned about viruses and virus infections in rela-
tively simple systems, diseases in the animal and their control are still of par-
amount importance. Contemporary virological research, then, must maintain 
a proportionate balance between studies at the cellular and subcellular levels 
and	those	conducted	within	the	animal	host.	Use	of	health-defined	animals	
in experimental programs in recent years has greatly strengthened the posi-
tion of those who would attempt to gain understanding of disease processes 
in the animal. 
Health- Defined Animals
The	 terminology	 to	 be	 used	 in	 the	 chapter	 relating	 to	 the	 definition	 of	
state	 of	 health	 of	 animals	 includes	 “germ-free,”	 “pathogen-free,”	 “specific	
pathogen-free,”	 and	 “conventional.”	 “Germ-free”	 is	 defined	 as	 an	 animal	
free of all other life and one that exists in an uncontaminated environment. 
This	 is	 an	 idealistic	 state	 to	which	Reyniers	 (2)	 ascribes	definite	 limitations	
based	on	our	current	knowledge	of	living	things.	“Pathogen-free”	is	defined	
as a state of freedom from microorganisms which would be harmful to the 
animal. This is a state of health that can be obtained in a practical manner for 
animals	which	may	be	used	experimentally.	“Specific	pathogen-free”	is	less	
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limiting	than	“pathogen-free”	in	that	specific	disease-producing	microorgan-
isms have been eliminated with safeguards to keep them continually out of 
the	SPF	population.	“Conventional”	is	defined	as	a	state	of	associated	micro-
bial life within an animal which may include harmful or disease-producing 
microbes as well as harmless ones. 
Germ-free and pathogen-free animals have essentially the same origin. 
With few exceptions, the fetal animal lives within its mother in a germ-free 
state. Aseptic delivery of the fetus near term by hysterectomy or caesarean 
section into a sterile environment retains the germ-free status of these ani-
mals independently of the maternal environment. Raising germ-free ani-
mals	is	difficult	because	of	the	precise	manner	in	which	they	must	be	fed	and	
housed to keep them free of all bacteria and viruses. The pathogen-free ani-
mal	is	less	difficult	to	raise	as	it	may	be	gradually	adapted	from	its	germ-free	
state at birth to accept, in the digestive tract, saphrophytic bacteria. The SPF 
animal is a derivative of either germ-free or pathogen-free animals and may 
be	obtained	by	natural	birth.	Adequate	environmental	control	is	essential	to	
retain freedom from undesirable microbiota. Reviews relative to the germ-
free state and its consideration to the time of Pasteur have been made by Rey-
niers (2), Luckey (3), and Gordon (4). A review relative to the procurement 
and rearing of pathogen-free and SPF pigs has been made recently by Young 
(5), whereas Meyer et al. (6) have described their experiences with germ-free 
pigs. A bibliography by Teah (7), which encompasses germ-free research 
from 1 885-1963, would serve as a useful background for persons interested 
in this subject area. 
The	germ-free	and	pathogen-free	animal	eliminates	some	of	the	difficul-
ties which have limited investigators of virus diseases of animals by provid-
ing	 suitable	 experimental	 hosts.	 Many	 viruses	 are	 host-specific	 and	 resist	
adaptation to other animals as well as to tissue culture systems or embryo-
nated hen’s eggs. The ideal experimental host would be an animal of the spe-
cies naturally susceptible to the virus but which comes from herds that have 
had no previous experience with the virus under investigation. Such animals 
should preferably be free of other viruses which might be activated from la-
tency during the course of experimentation, thereby complicating interpreta-
tion of the clinical disease. It is nearly impossible to obtain such a host from 
a natural environment because at birth they are exposed to all respiratory 
and enteric viruses and many types of bacteria common to their dam. Ani-
mals derived by hysterectomy or caesarean birth and properly raised in iso-
lation,	fulfill	many	of	the	needs	for	specific	experimental	hosts.	Not	only	are	
these animals pathogen-free but many, such as the calf, lamb, and pig, are 
antibody-devoid because the lactoglobulin-rich colostral milk is not ingested 
at	birth	as	would	occur	in	nature	since	these	animals	are	fed	artificial	diets.	
These animals are referred to as pathogen-free colostrum-deprived. 
Natural disease in animals may be complex. To isolate a single entity and 
ascribe the intensity of disease to that one entity may be misrepresentative. 
Several entities, i.e., viruses, bacteria, and other parasites, may act simulta-
neously or in succession to produce a disease state which cannot be obtained 
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with a single entity. A review of the earlier literature relative to this type of 
situation in animal diseases has been presented by Olson (8). The study of 
such complex situations using “conventional” animals is essentially fruitless 
because of the multiplicity of unknowns in the microbial background of such 
a host. By contrast, the PFCD animal is satisfactory because the correspond-
ing entities may be added singly or in unison to approach the complex situ-
ations encountered in a natural infection. Yager (9) has discussed the useful-
ness of these animals in experimentation. 
Pathogen-free colostrum-deprived calves (10), lambs (11), and pigs (5) are 
being	used	as	experimental	hosts	to	aid	in	the	definition	of	virus	diseases	of	
these species. Pigs have been used most liberally in this respect because of 
their availability and relatively lower costs. The sow generally has 8 to 12 
pigs per litter, whereas the ewe and cow generally present single fetuses. 
Since the pig has been used most liberally both in this laboratory and others, 
the interpretation of virus infections in animals through research with PFCD 
pigs will receive emphasis in this chapter. 
Immunity in Health-Defined Animals
There are several basic differences in immunity in our domestic animals 
in contrast to most other animals and man, which must be considered in a 
discussion of virus diseases and their control. Whereas there is a degree of 
placental transfer of globulins from mother to fetus in man, rodents, and 
carnivores, our domestic animals do not share this trait. The placenta of the 
mare, the cow, the ewe, and the sow acts as a barrier to the transport of glob-
ulins. For example, Kulangara & Schechtman (12) report that neither albumin 
nor globulins were present in the blood of the newborn calf. Albumin and 
some globulin were present in the blood of newborn kittens. Both albumin 
and globulins were present at birth in guinea pigs. Concepts differ as to why 
these species variances occur. 
The concept advanced by Brambell toward the prenatal transference of 
antibodies	as	interpreted	by	Payne	&	Marsh	(13)	may	be	summarized	as	fol-
lows: The blood level of antibodies at the time of birth is directly correlated 
with the development, persistence, and time of withdrawal of the yolk sac 
into the umbilical cord. In the newborn animals which have a relatively high 
level of blood antibody, the yolk sac is exposed to the uterine lumen during 
most of gestation. Animals which have only a slight globulin level at birth 
(calf, horse, pig) withdraw the yolk sac into the umbilical cord early in gesta-
tion and there is little prenatal absorption. This explanation is in contrast to 
the common opinion expressed by Mason & Dalling (14) that the number of 
layers of the maternal and fetal placentae determines the transfer of antibod-
ies. By this interpretation, transfer of antibody decreases as the placental lay-
ers increase. 
The	newborn	foal,	calf,	lamb,	or	piglet	are	born	without	adequate	globu-
lins to protect them from infectious entities present in their natural environ-
ments.	Protection	is	naturally	acquired	through	ingestion	of	the	lactoglobu-
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lins	in	the	colostral	milk	of	the	dams.	The	globulins	thus	acquired	represent	
only those diseases and antigenic stimuli experienced by the dams previ-
ously, and to which the dams responded with antibody production. 
Some recent comprehensive studies on globulin absorption by Payne & 
Marsh	(13,	15),	utilizing	fluorescein-labeled	gamma	globulins	and	PFCD	pigs	
have disclosed some interesting relationships. Intestinal cells apparently fol-
low the all-or-none law of physiology. The cells seem to engulf all the globu-
lins they can contain before allowing any to pass through the base of the cell 
into	the	lymphatics.	The	intestinal	cells,	on	first	contact	with	globulin,	will	ac-
cept heterologous globulin from other species although homologous globu-
lin does appear to be preferentially absorbed. Absorption takes place for a 
limited time only after contact with globulins or other proteins. Exposure to 
milk protein or other protein before exposure to globulin conditions the cells 
to be refractory to globulin absorption. 
When	 fluorescein-labeled	 gamma	 globulin	 was	 injected	 directly	 into	
the ligated small intestine of the newborn PFCD pig 24 hr after feeding, 
there was no absorption anterior to the ligature. There was always active 
absorption in the posterior segment where the gut had not been exposed to 
protein. When normal cow colostrum was fed to a pig in which the small 
intestine had been ligated, the blood level of gamma globulin rose to ap-
proximately the normal level of the nursing pig, yet the starved segment re-
tained its ability to absorb. In other experiments designed to study the in-
fluence	of	a	high	blood	 level	of	gamma	globulin	on	absorption,	 relatively	
large amounts of fractionated colostral gamma globulin were injected into 
the peritoneal cavity. The high blood level of gamma globulin absorbed 
from the peritoneal cavity failed to alter the absorptive ability of intestinal 
cells in previously starved pigs. It thus appears that the epithelial cells of 
the small intestine must be exposed to a soluble protein from the direction 
of the microvilli and not from the direction of the capillary bed, to lose their 
capacity to absorb globulin. 
A previous concept of active and passive immunity was that the new-
born calf, lamb, or pig is born without antibody. In more recent investiga-
tions, measurements of serum proteins by electrophoresis indicate that small 
amounts of globulin or globulin-like substances are present in the serum of 
the	 newborn	 animal	 before	 it	 suckles	 its	 dam.	 The	 significance	 of	 this	 has	
been studied by several different groups with varying opinions as to its sig-
nificance.	Segre	&	Kaeberle	 (16,	 17)	used	 the	PFCD	pig	as	an	experimental	
host in their studies of the mechanics of antibody formation. Diphtheria and 
tetanus	toxoids	were	used	as	specific	antigens.	These	researchers	believe	that	
the small amounts of globulin-like material result from a degree of placen-
tal transfer of maternal antibody. These globulin-like materials form a base 
for antibody production following stimulation of the newborn pig with an-
tigenic material related to the transferred antibody. The ability of the PFCD 
pig to produce some antibody to tetanus toxoid but not to diphtheria toxoid 
was attributed to contact of the dam during gestation to tetanus organisms 
with production of slight amounts of tetanus antibodies. These theoretically 
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passed the placental barrier to become the globulin-like base from which ac-
tive tetanus antibody was produced after birth following injection of tetanus 
toxoid. Segre & Kaeberle did not consider the possibility that tetanus toxins 
might pass the placental barrier and initiate active immunity in the fetuses. 
This concept is as plausible as the one they present. 
Payne	&	Marsh	 (13,	 15)	 also	 recognized	 the	presence	 of	 small	 amounts	
of globulin or globulin-like substances but hesitated to identify them as true 
globulin.	Sterzl	et	al.	(18)	have	presented	data	which	suggested	to	them	that	
the gamma globulin in the pig at birth is not antibody. This concept would 
be supported by the experiences of Young and Underdahl who have used 
several thousand PFCD pigs in virus transmission experiments beginning 
in 1949. The PFCD animal has been consistently susceptible to all viruses 
studied. 
New	findings,	which	have	similar	significance	 to	 the	finding	of	globu-
lin-like substances in the serum of the newborn animal, point toward stim-
ulation of active immunity of the fetus late in gestation by viral infections. 
In these instances, the virus must be mild enough to elicit infection without 
serious damage to the fetus. Weiss (19) demonstrated active immunity in 
newborn lambs that had originated from ewes experimentally infected with 
Rift Valley Fever virus late in gestation. Few animals were used but the ev-
idence was convincing enough to stimulate and warrant further study in 
this	field.	Aiken	&	Blore	(20)	were	similarly	able	to	demonstrate	production	
of active immunity to hog cholera in the swine fetus by the introduction of 
modified	live	virus.	Since	these	viruses	are	apparently	incapable	of	reach-
ing the fetus late in gestation by natural means, these researchers intro-
duced the virus directly into the fetus through the uterine wall of the sow 
after surgical invasion of the abdominal cavity. Fetuses so treated were im-
mune to challenge with virulent hog cholera virus after birth by hysterec-
tomy. Nursing was not permitted so that immunity was active rather than 
passive in nature. A similar relationship, demonstrating that the fetus is 
competent to develop antibodies, has been reported by Fennestad & Borg-
Petersen (21) for Brucella-infected calves and bovine fetuses injected with 
Leptospira. The apparent inability of the newborn animal to develop active 
immunity thus does not appear to be due to incompetence but rather to 
interference	by	specific	lactoglobulins	absorbed	from	the	dam’s	milk.	This	
phenomenon is discussed below. 
Although the globulins absorbed from colostrum serve to protect the 
newborn animal by passive immunity from those diseases which were pre-
viously	experienced	by	the	mother,	some	practical	difficulties	arise	from	this	
type of immunity in livestock production. The antibodies absorbed from co-
lostrum protect cells from invasion by viruses introduced purposely as vac-
cines to elicit active immunity. When the newborn animal has nursed before 
injection with virus, cell receptor sites may be blocked, virus produced may 
be	neutralized	by	passive	antibodies,	and	active	immunity	is	not	stimulated	
because	of	insufficient	viral	antigen.	This	phenomenon	is	generally	referred	
to as antibody block. Hoerlein (22) demonstrated some of the basic princi-
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ples, using killed antigens. Examples involving viruses are cited by Aiken 
(23), Coggins (24), Dunne (25), Weide and co-workers (26, 27) for hog cholera 
in pigs; Bekkum & Frenkel (28) for foot-and-mouth disease in pigs; Livings-
ton & Hardy (29) for bluetongue in lambs; Weiss (19) for Rift Valley fever in 
lambs; and Brown (30) for rinderpest in calves. 
In	most	 instances,	antibodies	act	 to	abort	specific	diseases	or	at	 least	 to	
modify them. Control of transmissible gastroenteritis, however, depends 
on continual nursing of the immune dam having some level of antibody in 
the milk, according to Haelterman (31). The surface of the intestinal cells is 
coated with antibody and the enteritis virus is unable to attack cells in suf-
ficient	numbers	 to	manifest	apparent	disease.	Placement	of	 the	pigs	which	
have received colostral antibodies to gastroenteritis on a nonimmune sow 
to suckle, results in loss of resistance and frank fatal infection even though 
these pigs have circulating antibodies which are ingested earlier from an im-
mune dam. 
Virus Infections During Gestation
Use of the total animal is essential in investigations of virus infections of 
the	mother	during	gestation	and	the	evaluation	of	their	influence	on	the	de-
veloping fetus. Incrimination of the infectious agent in naturally occurring 
disease has been based largely on circumstantial evidence. Reviews of these 
relationships have been presented by Blattner & Heys (32) and Rhodes (33, 
34) in general, and by Roberts (35) as pertains to the veterinary literature. 
The viruses which have been associated with disturbances of fetuses in 
domestic animals may be placed in two categories. They are: (a) viruses iden-
tified	with	resorbed,	malformed,	or	aborted	 fetuses	 in	natural	or	manmade	
infections, and (b) viruses used experimentally to reproduce those situations 
observed in nature. Only those instances in which either a known viral entity 
was	 specifically	 introduced	or	 a	viral	 entity	was	 isolated	 from	 fetal	 tissues	
are	included	in	the	first	category.	Representative	viruses	which	have	been	re-
ported to have an association with the development of embryonic or fetal dis-
turbances in swine, sheep, and cattle are listed in Table I. Viruses associated 
with similar disturbances for horses are not listed. 
The current popular interpretation of the involvement of viruses in fe-
tuses is based on the early observations of Gregg (55) in Australia. Rubella 
virus	 which	 infected	 women	 during	 the	 first	 trimester	 of	 pregnancy,	 was	
blamed	for	adverse	influences	on	the	developing	fetus.	The	most	severe	dam-
age was done to those fetuses attacked early, with more moderate damage 
to those near the third month of gestation. Teratologic damage primarily in-
volved the eyes and ears, and, to a lesser extent, the heart and brain. Similar 
patterns have been suspected for mumps virus infection but the evidence is 
vague. 
A response in animals similar to the one observed as the result of rubella 
infections in pregnant women involved a rabbit-attenuated hog cholera virus 
(36).	This	modified	virus	was	utilized	in	a	vaccine	intended	for	the	immuni-
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zation	of	swine	against	the	naturally	occurring	disease.	Vaccination	of	preg-
nant	sows	during	the	first	30	days	of	gestation	resulted,	at	term,	in	a	high	in-
cidence of stillborn pigs and live pigs with ascites. Since the gestation period 
of	the	sow	is	114	days,	the	30-day	period	is	comparable	to	the	first	trimester	
of pregnancy in women. This attenuated cholera virus did not adversely af-
fect fetuses when used in sows several days before conception or after the 
first	30	days	of	gestation.	
Experiences	similar	 to	 those	described	with	modified	cholera	virus	vac-
cines have been encountered with other viruses intended as aids in the con-
trol	 of	 animal	 diseases.	 Shultz	&	DeLay	 (43)	 have	 described	 losses	 among	
newborn lambs which were associated with the vaccination of pregnant ewes 
with attenuated strains of bluetongue virus. The pattern was similar to that 
described for rubella and hog cholera with the maximal effect on the ovine 
fetuses in those ewes vaccinated between 35 to 45 days. The normal gestation 
period of the ewe is 150 days, hence the fetus is most vulnerable within the 
first	trimester	of	pregnancy.	
Experiments designed to elucidate the effects of viral infections of the 
mother during gestation on the developing fetuses must be both carefully 
Table I. Animal Viruses Associated with Damaged Fetuses in Pregnant Dams
Species and Virus Literature Cited*
Bovine
	 Epizootic	bovine	abortion	 Kennedy	et	al.	(52);	Storz	et	al.	(53)
 Infectious bovine rhinotracheitis McKercher & Wada (54)
Ovine
	 Bluetongue	 Shultz	&	DeLay	(43)	
 Rift Valley fever Findlay (44); Weiss (19)
 Wesselsbron Weiss et al. (45); Belonje (46);  
      le Roux (47)
 Ovine abortion Parker & Younger (48)
 Middelburg Kokernot et al. (49)
 Friend Mirand & Grace (50)
 Ornithosis Pierce et al. (51)
Swine
	 Modified	hog	cholera	 Young	(36,	37);	Young	et	al.	(38);		 	
      Stair et al. (39)
	 Japanese	B	encephalomyelitis	 Burns	(40);	Shimizu	et	al.	(41)
 Pseudorabies Gordon & Luke (42); Stair et al. (39)
 * Not listed unless clear identity of virus associated either through isolation of vi-
rus	or	injection	of	specific	viral	entity.	References	not	intended	to	be	all	inclusive	
but representative. 
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planned and interpreted since interactions between several dynamic biologi-
cal systems are involved. The mammalian embryo transcends from the union 
of sperm and ovum into a complex multicellular organism within a very 
short time. The embryo in swine, for example, is virtually completed within 
30	days	 or	 approximately	 the	 first	 trimester	 (56).	 The	 elaboration	 of	 estab-
lished systems and growth of the fetus occur during the last two-thirds of the 
gestation period. 
The virus-embryo host system must be considered independently of the 
virus-maternal host system from several aspects. Whereas the maternal host 
has a complex array of defenses against lethal infection, the embryo host has 
essentially none. The placenta acts as a barrier to the passage of globulins so 
that immunity developed by the dam against the invading virus is unable to 
control virus infection in the embryo. Once the virus reaches the embryo, it 
may	multiply	unchecked	by	neutralizing	antibodies	of	the	dam.	
Experimental evaluation of embryonic viral infections of domestic ani-
mals must essentially be done within the given species. Studies in mice, rats, 
guinea pigs, or carnivorous animals in general are not comparable. In these 
species, globulins do pass the placenta so that viral infections of the fetus 
may	be	influenced	by	neutralizing	antibody	of	the	mother.	The	logical	means	
of transport of the virus to the embryo is by the blood stream of the dam 
during viremia. Since viremia would result from progressive multiplication 
of virus in the mother, the maternal antibody-producing mechanisms would 
have been stimulated prior to transport of the virus to the fetus. The fetal in-
fection	could	thus	be	 influenced	by	antibody	of	the	dam,	the	production	of	
antibody being initiated earlier by virus attack on the maternal host system. 
A	lead	time	of	several	hours	might	be	significant	in	many	virus-host	systems.	
The choice of virus for an experimental study of maternal-fetal infections 
depends on the type of situation which is to be reproduced. The rubella-mod-
ified,	cholera	virus-modified	bluetongue	virus	type	of	situation	requires	the	
choice of a mildly pathogenic virus. The infectious agent must be capable of 
attack	on	fetal	cells	but	be	sublethal	in	its	total	effect.	The	virus	inflicts	terato-
logic damage with abnormalities of the eyes and ears (rubella virus), general-
ized	edema	and	ascites	(modified	cholera	virus),	or	hydrocephalus	(modified	
bluetongue virus). 
In most instances in domestic animals, the fetus is killed by the virus. The 
time	of	death	relative	to	the	end	of	the	normal	gestation	period	influences	the	
clinical manifestations of the disease. An attack on the dam during the em-
bryonic stage of the developing young may result in the death of the embryo 
or embryos with complete or nearly complete aseptic (bacterial) absorption. 
Initiation of pregnancy with well-implanted corpora lutea prevents the dam 
from return to estrus even though the embryos have been destroyed. The pla-
centa may be retained and also resorbed. 
Attack	of	embryos	or	fetuses	after	they	have	reached	some	size	presents	a	
different picture. If all embryos are destroyed, abortion may occur with shed-
ding of fetuses and placental tissues. Fetuses in multiparous animals such as 
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the sow may die at different intervals in the gestation period. One living fe-
tus	is	adequate	to	maintain	pregnancy.	Expulsion	of	the	placenta	with	fetuses	
in all stages of resorption at term may result. Such a situation is presented 
pictorially by Young et al. (38) in an experimental litter which was damaged 
by	modified	cholera	virus.	
The SPF sow has been a useful experimental animal for the study of vi-
rus-maternal-fetal relationships. The pathogen-free background limits the 
types of infectious entities that might complicate the interpretation of re-
sults. The sow is multiparous and generally has 8 to 12 fetuses, each of 
which is in its own placental sac. These fetuses are distributed uniformly 
along	the	entirety	of	a	two-horned	uterus.	Stair	(57)	has	utilized	a	bifid	hys-
terectomy to take advantage of this anatomic structure in the study of virus 
infection of the fetus. The dam may be infected early in gestation. Follow-
ing her initial recovery from the virus infection, one horn of the uterus is re-
moved surgically for study of the effects of the virus on the embryo. The 
other horn is left intact. The embryos in this horn may be left for later re-
moval and study of more advanced stages of embryonic infection, or the fe-
tuses may be left to mature. They may be delivered by a total hysterectomy 
near the end of gestation. 
The	 identification	 of	 virus	 locale	 has	 not	 been	 possible	 by	 many	 tech-
niques	used	to	associate	virus	with	damaged	or	dead	embryos	or	fetuses.	In-
oculation of experimental animals or tissue culture systems with suspension 
of triturated tissues from embryos may indicate the presence of virus but 
does not identify the site of the virus in the embryo. Stair et al. (39) have uti-
lized	fluorescent-tagged	specific	antiglobulins	to	demonstrate	both	hog	chol-
era and pseudorabies virus in embryonic or fetal tissues. 
Patterns of attack differ so that each virus-host system must be consid-
ered	 separately.	Modified	 hog	 cholera	 viruses	 fit	 the	 conventionally	 con-
sidered pattern based on the evaluation of rubella virus infections in preg-
nant	women.	Attack	of	 the	 embryo	during	 the	first	 trimester	 of	 gestation	
results in teratologic or lethal damage to the embryo. Virus is demonstra-
ble	 in	 fetal	 reticuloendothelial	 tissues	by	 immunofluorescence	 techniques.	
Maternal infection which occurs later in gestation generally results in fail-
ure	of	 the	virus	 to	 reach	 the	embryo.	 Immunofluorescence	 techniques	 fail	
to disclose the cholera antigen deposited in fetuses. By contrast, pseudora-
bies virus appears to be incapable of establishing itself in the young swine 
embryo	 through	 the	first	 30	days,	 but	may	 reach	 the	 fetuses	 on	maternal	
infection during the last trimester of gestation. The effect on each fetus is 
all-or-none. Those embryos attacked are killed and give positive immuno-
fluorescence	tests	for	pseudorabies,	whereas	those	which	are	not	killed	are	
normal at birth by hysterectomy and susceptible to infection on experimen-
tal challenge in isolation as PFCD pigs. When all fetuses are killed, the lit-
ter is aborted (39). These relationships are not unlike those encountered in 
women (33). Smallpox and chickenpox viruses attacking the mother early in 
pregnancy behave similarly to pseudorabies virus in that they do not cause 
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birth defects in the baby. Attacks late in pregnancy may result in the pas-
sage of virus across the placenta to invade the tissues of the fetus. The new-
born infant may have the same clinical disease as the mother. Rubella virus 
behaves	similarly	to	modified	hog	cholera	in	that	early	infection	may	dam-
age the embryo, whereas infection of the mother late in pregnancy rarely 
affects the baby. The newborn infant is born healthy in such a case. Cox-
sackie and ECHO viruses may cause a feverish illness with a rash which 
closely resembles that produced by rubella virus. There has been no evi-
dence of birth defects among infants from thousands of mothers infected 
with these viruses in the early months of pregnancy. Similarly, vaccination 
with vaccinia or polio viruses has failed to cause abortions or birth defects. 
Quite	 likely,	 the	 enteroviruses	 of	 domestic	 animals	 fit	 this	 type	 of	 situa-
tion.	No	definite	conclusions	can	be	drawn	because	experimental	evidence	
is lacking. 
Respiratory Infections
Influenza — A discussion of respiratory diseases in animals should in-
clude	 consideration	 of	 swine	 influenza.	 The	 primary	 entity	 of	 this	 disease	
is	a	filterable	virus	which	causes	only	moderate	disease	as	a	single	entity	in	
PFCD pigs or in susceptible conventional pigs. Shope (58) referred to this 
transient	 infection	 in	 conventional	 pigs	 as	 “filtrates	 disease.”	 Swine	 influ-
enza	as	a	clinical	disease	was	defined	by	Lewis	&	Shope	(59)	as	a	concerted	
disease	with	 the	 intensification	of	 the	primary	viral	disease	by	a	secondary	
infection with the bacterium, Hemophilus influenzae suis. As an explanation 
for	the	fact	that	swine	influenza	persisted	from	year	to	year	on	midwestern	
farms, Shope (60–63) presented circumstantial evidence which involved the 
swine lungworm as an intermediate host. Lungworm eggs originating from 
swine	that	were	simultaneously	infected	with	swine	influenza	virus	and	par-
asites of Metastrongylus spp. were voided in the stools of sick pigs. These vi-
rus-contaminated lungworm eggs were ingested by earthworms, hatched, 
and encysted in larval stages in the musculature of the earthworm. The lar-
vae made their way into the lungs of susceptible pigs following ingestion by 
the pig of earthworms which had been infected with the lungworm larvae. 
Lungworms	reached	adult	stage	without	the	development	of	swine	influenza	
although the virus was considered to be present in a “masked” stage. Overt 
influenza	was	precipitated	by	stress	resulting	from	experimental	injection	of	
Ascaris suum extracts. 
There has been general reluctance to accept Shope’s explanation of an in-
termediate	 parasite	 host	 as	 a	means	 of	 perpetuating	 swine	 influenza.	 This	
reluctance has not been on an editorial level but rather on a conversational 
level. It has stemmed from inability to identify the virus in any manner from 
the time it leaves the swine host until it again manifests itself as a disease en-
tity in the animal. Attempts by Shope to demonstrate the virus in Metastron-
gylus spp. eggs or larvae failed. 
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Approximately 20 years after Shope’s explanation was presented, two 
separate	 groups	 of	 researchers	 published	 confirmatory	 results.	 Sen	 et	 al.	
(64)	were	 the	first	 to	 confirm	Shope’s	findings	by	utilizing	PFCD	pigs	 in	 a	
well-defined	 and	 controlled	 isolated	 environment.	Kammer	&	Hanson	 (65)	
obtained similar results. Neither of these research groups was able to iden-
tify	the	swine	influenza	virus	in	the	intermediate	stages.	Peterson	et	al.	(66)	
have demonstrated, however, that swine lungworms contain receptorlike 
substances	 capable	 of	 absorbing	 influenza	 virus,	 a	 result	 consistent	 with	
Shope’s	hypothesis.	Unquestionably,	 the	virus	 is	 transported	 in	some	man-
ner through a Metastrongylus-egg-earthworm-Metastrongylus larvae cycle to 
remain potentially infective for the susceptible pig. Perhaps “masking” in ac-
tuality	 is	 the	presence	of	virus	 in	amounts	 less	 than	 those	 required	 to	pro-
duce experimental infection, as suggested by Beard (67) for papilloma virus. 
Since the presence of Metastrongylus spp. in the lungs of pigs has been shown 
by	Underdahl	&	Kelley	(68)	to	enhance	influenza	infection,	less	virus	may	be	
needed	 to	 initiate	 influenza.	 It	 is	a	 challenge	 to	 researchers	 to	establish	 the	
mechanisms by which these things are accomplished. 
Ascariasis enhancement of respiratory infections	—	The	significance	of	
the extract of A. suum used by Shope in his early work may be related to the 
recent	findings	of	Underdahl	(69),	Underdahl	&	Kelley	(68),	and	Nayak	et	al.	
(69a). The life cycle of this parasite has been partially understood for many 
years. Embryonated eggs are ingested from the soil by pigs and hatch in the 
stomach and intestines. The larvae pass through the intestinal wall, through 
the liver, and through the lungs. Many of the larvae are eventually coughed 
up and swallowed, to reach the intestinal tract for the second time. Some of 
the parasites grow into adults with the females laying large numbers of eggs. 
These eggs may persist in the soil for years, to be ingested by other pigs and 
thereby perpetuate ascariasis. 
The passage of a few thousand ascaris larvae through the liver and lungs 
of pigs causes only moderate stress. It takes large numbers, possibly larger 
than generally occurs in nature, to cause marked clinical illness among ex-
perimentally infected animals. Once the larvae pass through the lung, the 
pigs soon return to an apparent state of normalcy. 
Partial concern for the effects of migrating A. suum larvae is related to the 
enhancement	of	respiratory	virus	infections.	Swine	influenza	is	greatly	inten-
sified	when	the	larvae	pass	through	the	virus-infected	lung,	and	severe	clin-
ical illness is manifested by doses of virus and parasite which, as single en-
tities, would not cause noticeable illness (69). In some manner, the migrating 
parasite lowers local host resistance to permit virus multiplication. The ef-
fect, more logically, would appear to be related to the secretion of substances 
which enhance virus multiplication rather than due to simple mechani-
cal damage. Considerable hemorrhage is associated with the passage of lar-
vae through the lungs. The migrating larvae do elicit an increase in amino 
acid amidase activity, an activity also associated with the virus infection (70). 
Other	enzyme	systems	may	be	similarly	imbalanced.	
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The	natural	opportunity	for	associated	migrating	larvae	and	swine	influ-
enza	virus	to	cause	illness	is	limited	to	an	approximate	10	per	cent	incidence	
of	influenza	(71)	in	swine	populations	of	the	midwestern	United	States.	The	
A. suum parasite is more widely disseminated and is estimated by Kelley et 
al. (72) to contaminate over 85 per cent of premises on which American swine 
are	 raised.	A	 less	 likely	 virus-parasite	 combination	 involves	 influenza	 and	
lungworms since this parasite is present on only about 20 per cent of mid-
western farms (73). 
Virus pneumonia of pigs — A more opportune natural involvement of 
A. suum larvae in swine respiratory disease is presented with virus pneumo-
nia of pigs. It has a wide distribution among the swine populations of the 
world (74) and has been shown by Underdahl & Kelley (68) to be enhanced 
by migrating A. suum larvae. Since the pneumonia virus is present in approx-
imately 40 per cent of midwestern United States swine (75) and tends to per-
sist	 indefinitely	 in	 the	 lungs	of	 the	 infected	animals,	 the	probability	of	pigs	
having both pneumonia virus and migrating A. suum larvae simultaneously 
is not remote. Virus pneumonia is perpetuated on passage of the virus from 
mother to offspring by carriers. The agent has been demonstrated by Betts 
(76) to persist for at least 66 weeks in the pig and to retain the capacity to in-
fect other pigs. 
Virus pneumonia of pigs may or may not be the proper terminology for 
the	chronic	respiratory	disease	of	swine	which	is	clinically	characterized	by	
persistent coughing, and histopathologically by perivascular and peribron-
chiolar	 cuffing	with	 large	 and	 small	 round	 cells.	 This	was	 the	 name	given	
by Betts (76) in an early and excellent description of the disease. Lamont (77) 
had presented an earlier review encompassing respiratory diseases of swine 
in	general	but	failed	to	categorize	pneumonia	as	a	distinct	entity.	A	review	
by Young (74) supplements earlier reports. 
Virus	 pneumonia	 is	 induced	 by	 the	 introduction	 of	 filtrates	 of	 infected	
lung intranasally or intratracheally into susceptible swine. Relatively coarse 
filters	must	be	used	to	prevent	passage	of	pleuropneumonia-like	organisms.	
Bakos	&	Dinter	(78)	report	the	isolation	of	a	swine	enzootic	pneumonia	or	vi-
rus	pneumonia	agent	by	yolk	sac	inoculation	of	 lung	filtrates	from	infected	
swine. After inoculation their agent may be cultivated on PPLO agar. Betts 
& Whittlestone (79) also were able to cultivate pleomorphic organisms about 
0.4 μ in diameter in pig-lung-monolayer tissue culture and culture material 
was capable of producing lesions typical of virus pneumonia in PFCD pigs. 
A similar agent has been described by Goodwin & Whittlestone (80). These 
experiences are at variance with those obtained with the virus isolated and 
studied by Urman et al. (81), in that the NB-12 strain used has resisted cul-
tivation in tissue culture and embryonated eggs. Pleuropneumonia-like or-
ganisms isolated from pneumonic lungs of market swine at slaughter in 
Nebraska by Plonait (82), failed to become established in the lungs of exper-
imentally inoculated PFCD pigs. To further confuse the etiologic interpre-
tation of virus pneumonia, Goodwin & Whittlestone (83) have recently de-
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scribed a respiratory disease of pigs, designated Type XI, which differs from 
either	enzootic	or	virus	pneumonia	yet	is	similar	in	many	respects.	Thus,	the	
probability exists that there are several infectious entities which produce sim-
ilar respiratory diseases in swine. 
Comparison of diseases which occur in different countries is generally ac-
complished	most	satisfactorily	by	tests	for	similarities	in	serum	neutralizing	
antibodies	produced	 in	 the	natural	host.	The	difficulty	with	virus	pneumo-
nia	 is	 that	measurable	neutralization	by	 serum	antibodies	 is	not	 elicited	 in	
infected swine according to Bornfors & Lannek (84) even though recovered 
swine were resistant to reinfection. Several other research groups have had 
similar	experiences.	The	 indirect	approach	of	Bakos	&	Dinter	 (78),	utilizing	
serum	from	hyperimmunized	rabbits	for	specific	neutralization,	immunoflu-
orescence, and agar-gel precipitation tests might be useful for comparisons. 
Direct	immunofluorescence	tests	attempted	in	this	laboratory	with	globulins	
prepared from serum of virus pneumonia-infected pigs have not been suc-
cessful.	Antibody	production,	which	is	essential	to	provide	a	specific	globu-
lin	to	which	fluorescein	may	be	attached	for	the	immunofluorescence	has	not	
been	satisfactory	even	though	pneumonia	infections	were	intensified	by	as-
cariasis and administration of cortisone (85). 
Broad spectrum antibiotics will prevent the establishment of virus pneu-
monia in pigs but will not cure the disease once it is established [Bornfors & 
Lannek (84); Goret et al. (86); Hupka & Hutten (87)]. Treatment is not prac-
tical, however, as newborn pigs must be medicated individually and remain 
susceptible when the drugs are withdrawn. In an infected herd, therapeutic 
levels of antibiotics would need to be administered continuously. 
Infectious atrophic rhinitis of swine — Another disease of swine which 
is considered very important to the economy of pork production is infec-
tious atrophic rhinitis which has much in common with virus pneumonia. 
Both affect the respiratory tract although the former involves primarily the 
upper portion and pneumonia the apical and cardiac lobes of the lungs. 
These	 diseases	 are	 acquired	 by	 contact	with	 infected	 swine	 or	 the	 inhala-
tion of air contaminated by them. Both diseases are perpetuated in herds by 
carrier	animals	which	apparently	remain	carriers	over	sufficiently	long	peri-
ods to pass the diseases from one generation to the next. There is not com-
plete academic accord on the etiology of either rhinitis or pneumonia. The 
death of an animal is rarely attributed to either disease. Both diseases effect 
the	economy	of	production	through	retardation	of	rate	of	growth	and	ineffi-
cient	utilization	of	feed.	
An extensive review of the early literature relative to atrophic rhinitis 
made	by	Switzer	(88)	in	1955	indicates	the	confused	concept	of	the	etiology	of	
this disease. Many different bacteria, including PPLO, trichomonad parasites, 
and	several	viruses	have	been	suggested	as	its	cause.	Switzer	(89)	suggested	
that	several	agents	might	be	responsible	 for	 the	clinical	entity	 identified	by	
turbinate	atrophy	as	rhinitis.	Further	work	by	Switzer	and	his	associates	(90,	
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91), using tissue culture methods enabled them to identify nine viruses and 
two PPLO in the nasal cavities of swine. These agents were not generally ca-
pable of producing disease in naturally farrowed SPF pigs. The viruses were 
entities	other	 than	Coxsackie,	 influenza,	pseudorabies,	 or	virus	pneumonia	
(90). One bacterial entity, Bordetella bronchiseptica, which is believed by Swit-
zer	 (92)	 to	be	an	 important	 etiological	 agent	 in	atrophic	 rhinitis	possibly	 is	
eliminated and controlled by sulfonamide therapy. 
Neither rhinitis nor virus pneumonia appear to respond to therapy with 
known drugs and cannot currently be prevented by vaccines because none 
exist against these diseases. The use of sulfonamides as reported by Swit-
zer	 (92)	 to	control	or	eliminate	Bordetella bronchiseptica infection appears to 
be misleading because the experiences of American veterinarians in swine 
practice with rhinitis during the 1950’s contradict this. A recent develop-
ment in the American feed industry wherein sulfonamides are included as 
feed additives for swine should yield practical information on this point. 
A marked reduction in the disease should be effected among swine in the 
United States cornbelt. 
It	is	questionable	that	the	basic	etiology	of	rhinitis	has	been	determined.	
In the natural disease, young susceptible pigs are attacked, often with severe 
turbinate atrophy. Pathogen-free colostrum deprived pigs placed in contact 
with animals severely affected with natural rhinitis, develop marked atro-
phy. By providing a continuous series of contact PFCD pigs, the severe form 
of the infection may be progressively passed. This suggests the association of 
a viral entity(ies) with rhinitis which has not been consistently demonstrable 
by the methods used previously in its study. 
Porcine inclusion body rhinitis — The inclusion body rhinitis described 
by Done (93) does not appear to be the same disease or related to atrophic 
rhinitis. This disease has also been reported in Canada by Mitchell & Cor-
ner (94), in central Europe by Cohrs (95), and in the United States (Iowa) by 
Duncan et al. (96). The clinical disease is more acute than atrophic rhinitis but 
does not generally produce turbinate atrophy. Excessive exudation from the 
nostrils is typical. 
Infectious bovine rhinotracheitis —	The	isolation	and	characterization	of	
new viruses associated with illness among cattle has previously been ham-
pered by uncertainty of the immunological state or susceptibility of the ex-
perimental host. Tissue culture methods have been helpful in overcoming 
this limitation. Viruses isolated in tissue culture can be subjected to serum-
neutralization	tests	to	evaluate	possible	previous	encounter	of	individual	or	
groups	of	calves	to	 that	specific	virus	or	closely	related	viruses.	Studies	for	
pathogenicity of the tissue culture virus in experimental calves with known 
immune	status	have	much	more	significance.	
An example of the usefulness of tissue culture systems in evaluating bo-
vine virus diseases is evident from results obtained with the agent which 
causes infectious bovine rhinotracheitis. This is an acute upper respiratory 
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infection	 in	cattle	which	was	first	 isolated	by	Madin	et	al.	 (97).	The	disease	
was shown by McKercher et al. (98) to be caused by a single virus entity 
among dairy and feeder cattle in California as well as feeder cattle in Colo-
rado. Brown & Cabasso (99) succeeded in the experimental transmission of 
the disease. Infectious bovine rhinotracheitis virus has been shown by Gil-
lespie et al. (100) to be related to or to be the same virus as that which causes 
infectious pustular vulvovaginitis in cattle. Cheatham & Crandell (101) dem-
onstrated intranuclear inclusions associated with virus-infected tissue cul-
ture cells. This was later demonstrated in experimentally infected animals by 
Crandell et al. (102). 
Cultivation of the bovine rhinotracheitis virus in tissue culture [See Gil-
lespie	et	al.	(103)	;	Cabasso	et	al.	(104)	;	Schwartz	et	al.	(105,	106)]	and	mod-
ification	of	 the	virulence	of	 the	virus	has	made	vaccines	practical	 for	mod-
erating the natural disease. These vaccines are effectively and widely used, 
especially in large feed lots where thousands of cattle are being fattened for 
market.	 An	 intangible	 but	 definite	 impression	 exists	 among	 veterinarians	
that there are fewer total respiratory problems among rhinotracheitis-vacci-
nated	 cattle	 even	 though	 the	virus	had	not	previously	been	 identified	as	 a	
clinical entity within the population. The vaccines must be properly used as 
indicated by McKercher et al. (54), as vaccination has been associated with 
abortion among cattle. 
Bovine myxovirus parainfluenza 3 — Considerable progress has been 
made in recent years on the viral etiology of “shipping fever” in cattle. Re-
isinger et al. (107) succeeded in isolating a virus from calves ill with a respi-
ratory disease which has now been classed as a bovine myxovirus parain-
fluenza	3.	The	strain	designation	was	made	as	SF-4.	Several	research	groups	
have presented evidence based on serological studies that the virus is widely 
distributed in cattle. Hoerlein et al. (108) report antibodies in feeder calves 
in Illinois, whereas Abinanti et al. (109) reported later a widespread inci-
dence	of	parainfluenza	antibodies	among	cattle.	Kramer	et	al.	(110)	found	ev-
idence of a wide distribution of the virus in both beef and dairy cattle in Ne-
braska.	Dawson	(111),	on	comparison	of	his	T1	strain	of	parainfluenza	virus	
with the SF-4 American strain and the Umea 33 Swedish strain, found a gen-
eral relationship between all three strains of the organism. In contrast to this 
work, Hamdy et al. (112) report the production of a “shipping fever-like” 
syndrome with combinations of viruses and Pasteurella spp. The viruses used 
were	parainfluenza	3,	bovine	 rhinotracheitis,	 and	psittacosis	 lymphogranu-
loma venereum. 
Infectious bovine keratoconjunctivitis — Infectious bovine keratocon-
junctivitis (“Pinkeye”) is a disease of cattle which has a history similar to that 
of “Shipping Fever.” Satisfactory evidence for any bacterial agent as the pri-
mary cause of Pinkeye is lacking. Sykes et al. (113), however, have isolated a 
virus from cattle clinically ill with what they interpreted as infectious bovine 
keratoconjunctivitis. The failure of 7 of 12 heifers to become clinically ill even 
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though	by	serum	neutralization	tests	they	should	have	been	susceptible,	at-
tests to the mild effects of this agent. This virus was shown to be unrelated 
to	 bovine	 rhinotracheitis,	 bovine	virus	diarrhea,	parainfluenza	 3,	Nebraska	
mucosal disease agent (114), bovine respiratory virus, and pneumonoenteri-
tis virus. Experiments by Sweat (10) in PFCD calves kept in strict isolation in-
dicate	a	definite	primary	capacity	for	invasion	by	this	agent.	The	experimen-
tal	disease	is	characterized	mainly	by	dramatic	and	sudden	loss	of	weight	by	
calves but without corneal opacity typical of the infectious bovine keratocon-
junctivitis. Thus, it would appear that what is clinically referred to as Pink-
eye in cattle has an etiological background currently as vague as Shipping 
Fever. Obviously, much critical research is needed. The usefulness of PFCD 
calves (10) in these investigations is obvious but their availability and cost of 
approximately $250 per animal, plus the need for maximal isolation, are lim-
iting factors. 
Enteric Infections
Tissue culture systems have been used extensively in the study of viruses 
isolated from the intestinal tract of domestic animals. Considerable empha-
sis	 has	 been	placed	 on	 enteric	 viruses	 of	 swine	utilizing	 swine	 kidney	 cell	
cultures for the isolation (115) of viruses, and determination of their growth 
characteristics (116). Tissue culture systems have also served as the source of 
virus	for	purification	of	swine	enteroviruses	and	swinepox	viruses,	using	an	
ion exchange cellulose column (117). 
Swine polio-encephalomyelitis viruses — Comparison of the immuno-
logical relationships of polio-encephalomyelitis viruses has been made possi-
ble through the use of tissue culture systems. For example, Teschen disease, 
reviewed	by	Huck	 et	 al.	 (115),	 is	 an	 enzootic	 encephalitic	disease	 of	 swine	
in central Europe. The occurrence of similar diseases of swine in other geo-
graphic areas prompted comparative studies between virus strains. Evidence 
that several of these diseases are closely related or identical has been pre-
sented by several groups of researchers. Chaproniere et al. (119) grew Tal-
fan	virus	in	tissue	culture	and	used	infected	fluids	as	inoculum	to	reproduce	
the	disease	 in	pigs.	Cross	 neutralization	 of	Teschen	 and	Talfan	 antiserums	
disclosed similarities between the two diseases. Darbyshire & Dawson (120) 
found	a	similar	relationship,	using	a	complement-fixation	test,	and	also	com-
pared two other swine polio-encephalomyelitis viruses to Teschen and Tal-
fan viruses (T80 and T52A). Huck et al. (118), studying viruses isolated by 
Izawa	et	al.	(121),	demonstrated	that	the	California	isolated	viruses	E1	and	E4	
were related to Teschen and T80 groups of swine enteroviruses, respectively. 
The	E1	virus	was	associated	with	a	natural	epizootic	of	diarrhea	among	pigs,	
whereas the E4 virus was obtained from feces of a clinically normal pig. The 
T80 virus was isolated by Betts (122) from the tonsils of “normal” pigs and 
was	capable	of	producing	polio-encephalomyelitis	in	PFCD	pigs	(123).	Izawa	
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et al. (121) used SPF pigs of hysterectomy origin in evaluating the pathoge-
nicity of their viruses. The report of Huck et al. (118) presents a good review 
and	summary	of	research	in	this	field.	
The hemagglutinating virus of Greig et al. (124) which produced enceph-
alomyelitis in PFCD pigs (125) appears not to be related to the Teschenor T80 
groups of viruses. The F7 enterovirus of Kelly (126) had a minor antigenic re-
lationship to T80 virus but was distinct from Talfan, Teschen, S 180/4, T52A, 
and PE-1 porcine viruses. None of the viruses isolated in England or in the 
United States came from disease situations of the severe type associated with 
the virulent strains of Teschen virus of central Europe. 
Transmissible gastroenteritis of swine —The most dramatic enteric in-
fection that occurs among young swine is transmissible gastroenteritis. This 
is	a	highly	contagious	virus	disease	which	 inflicts	heavy	mortalities	among	
very young susceptible swine. Mortalities of 90 to 100 per cent occur among 
pigs	less	than	a	week	old.	The	disease	was	first	described	by	Purdue	research-
ers in 1946 and has since been reviewed by Doyle (127). All pigs 14 to 21 days 
old may manifest typical symptoms of vomition and diarrhea but 70 to 90 
per cent generally recover within a few days. Older pigs may exhibit a slight 
diarrhea for a few days then recover without loss. Silent or inapparent trans-
missible gastroenteritis infections occur and viremia was demonstrated by 
Young et al. (128) in asymptomatic pigs by the inoculation of their blood into 
very young susceptible pigs. Evidence of previous infection by six- to eight-
fold	 shifts	 in	 specific	 serum	neutralization	 antibodies	 can	be	demonstrated	
by	a	test	described	by	Young	et	al.	(129),	using	PFCD	pigs	less	than	five	days	
old	to	indicate	the	presence	of	virus	not	neutralized	in vitro. 
Study of transmissible gastroenteritis has been limited for all practical 
purposes to the experimental disease in susceptible pigs. The agent has re-
sisted adaptation to other species and to tissue culture systems. Lee (130) and 
Eto et al. (131) have reported adaptation of the virus to tissue culture. Most 
researchers in the United States, however, have had experiences similar to 
Haelterman’s (31) in that enteritis virus does not grow in tissue culture sys-
tems. The cultured viruses reported by Lee and Eto are either not gastroen-
teritis	or	have	characteristics	quite	different	from	those	of	the	strains	worked	
with in most American laboratories. 
Misinterpretations of transmissible gastroenteritis infection occur in spite 
of an accumulation of knowledge such as outlined above. For example, a 
severe	 enzootic	 of	 the	disease	manifested	 itself	with	 severe	 symptoms	and	
heavy	 losses	 among	 the	 young	pigs	 in	 a	moderate	 sized	herd.	 Forty	 addi-
tional sows were to begin farrowing within two weeks so these were isolated 
about	 one-half	 mile	 away.	 The	 farrowing	 quarters	 were	 evacuated,	 thor-
oughly cleaned, gassed with formaldehyde, and rested for two weeks prior 
to farrow of the new litters. Lack of evidence of gastroenteritis in the subse-
quently	 farrowed	litters,	 the	first	 interpreted	as	 the	successful	avoidance	of	
exposure of the new pigs to the virus. Actually, the dams had undergone in-
apparent infections even though precautions were taken to prevent their ex-
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posure.	Significant	rises	in	serum	neutralization	antibodies	from	none	in	pre-
exposure serums to 1:16 to 1:32 in postinfection serums, indicated that the 
dams had been infected. 
Transmissible gastroenteritis or like diseases among pigs have been re-
ported	from	several	other	countries	but	it	is	difficult	to	determine	if	the	dis-
eases are truly related. Roe & Alexander (132) reported a disease occurring in 
nursing pigs in Ontario which resembled gastroenteritis. These authors con-
cluded on clinical observations that the disease was not the same. A highly 
infectious gastroenteritis reported by Goodwin & Jennings (133, 134) among 
pigs in England also behaved like transmissible gastroenteritis in many re-
spects.	 Serum	 neutralization	 tests	 made	 with	 their	 infectious	 agent	 (134)	
against	 specific	 immune	 serums	 prepared	 in	 the	 United	 States	 (129)	 sug-
gested an immunologic relationship between the British disease and the Hor-
mel strain. It was not possible to determine the exact relationship. The lim-
iting	factor	for	neutralization	tests	for	transmissible	gastroenteritis	has	been	
the need to use very young susceptible pigs, preferably PFCD pigs, to dem-
onstrate	 neutralizing	 antibodies.	 Since	 the	 disease	 is	 highly	 transmissible,	
these	tests	must	be	conducted	in	isolation.	The	lack	of	adequate	isolation	fa-
cilities	and	available	pigs	has	 limited	studies.	A	good	serum	neutralization	
test in tissue culture would be useful should someone succeed in adapting 
the gastroenteritis virus to a culture system. 
Beran’s swine enterovirus — The	need	 for	 a	health-defined	 total	host	
to supplement tissue culture in the study of virus infections was empha-
sized	in	the	research	of	Beran	and	co-workers	(135,	136)	with	an	enterovi-
rus of swine. Beran’s enterovirus was isolated in tissue culture from stools 
of swine in a conventional population that was undergoing an enteric dis-
turbance. A cytopathic effect was obtained in a swine kidney cell tissue cul-
ture	 system	with	 this	 virus.	 Infected	 culture	 fluids	 given	 to	 conventional	
pigs produced erratic results. Tests made by Beran et al. (136) with PFCD 
pigs, however, gave conclusive and startling results. Beran’s enterovirus at-
tacked	the	intestinal	cells	of	these	pigs	and	elicited	neutralizing	antibodies	
without the manifestation of any clinical symptoms of disease. Tempera-
tures taken twice daily remained normal. There was no change in stool con-
sistency. Beran’s enterovirus of swine thus cannot be considered as a seri-
ous infectious entity, at least as far as the uncomplicated infection in pigs is 
concerned. 
Bovine virus diarrhea — A group of cattle diseases referred to generally 
as the virus diarrhea-mucosal disease complex has received considerable 
attention from veterinary researchers in the past several years. One prob-
lem has been the vague and variable nature of the disease(s) which form 
this complex. The virus diarrhea syndrome has been more easily evaluated 
than the mucosal disease as several virus diarrhea agents have been iso-
lated in tissue culture systems. The virus isolated by Underdahl et al. (114) 
from	what	was	believed	to	be	mucosal	disease	at	the	time	more	nearly	fits	
the diarrhea format. 
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Virus diarrhea is generally an acute or chronic, contagious febrile dis-
ease	 of	 cattle	 characterized	 by	 inflammation	 and	 erosion	 of	 the	 mucous	
membranes of the digestive tract associated with diarrhea, depression, de-
hydration, respiratory distress, and leucopenia. A major concern is the sim-
ilarity	of	 this	 infection	to	rinderpest	and	the	need	for	a	rapid	and	specific	
means	 for	differential	diagnosis.	Specific	neutralizing	antibody	can	be	de-
tected	for	the	diarrhea	virus	by	virus-neutralization	tests	similar	to	the	one	
described by Coggins (137). 
Several research groups have succeeded in isolating in tissue culture vi-
ral agents [See Baker et al. (138) ; Lee & Gillespie (139)] which have vary-
ing degrees of immunological relationship to each other. Whereas Carlson et 
al.	 (140)	 found	their	virus	diarrhea	under	field	conditions	 to	cause	mortali-
ties near 10 per cent (range 0 to 50 percent), no deaths occurred among calves 
infected in the laboratory. The virus isolated by Noice & Schipper (141) be-
haved similarly. This has been typical of transmission experiments both with 
diarrhea and mucosal disease, which suggests that all factors in the natural 
disease are not being encountered. Host susceptibility governed by previous 
experiences	with	the	same	or	similar	agents,	proper	sequence	of	preinfection	
factors and associated secondary bacteria, parasites or viruses, may not have 
been met in executing the experimental infections. Experiments conducted 
with	 PFCD	 calves	 utilizing	 agents	 isolated	 from	 viral	 diarrhea	 or	mucosal	
disease might prove to be more fruitful than experiments that have been con-
ducted using conventional calves. 
Although several virus diarrhea viruses have been cultivated in tissue 
culture,	field	use	of	a	vaccine	has	not	been	practiced.	A	multiplicity	of	di-
arrheal antigenic types would seem to be indicated plus some antigenic 
component(s) which would protect against invasion by mucosal disease vi-
ruses. A triple vaccine with leptospiral, diarrhea, and bovine rhinotrache-
itis antigens proposed by Baker et al. (142) has not been used beyond exper-
imental trials. 
Systemic Diseases
Hog cholera — Hog cholera continues to be one of the most important 
virus	diseases	in	swine	in	the	United	States.	It	was	first	identified	as	a	filter-
able virus by Dorset et al. (143) in 1904 on a follow-up of work described in 
the previous year. Historically, the popular belief of the origin of hog chol-
era is 1833 in Ohio. Hanson (144), however, in a critical re-evaluation, placed 
the	first	appearance	of	the	disease	in	the	United	States	at	Franklin,	Tennes-
see, around 1800–1810. Among the possible origins discussed was that the 
virus was imported in carrier animals from a country of poor husbandry in 
which	it	was	not	recognized	or	described.	This	explanation	seems	plausible	
based on the description by Fleming (145) of plagues in European swine in 
the late 1700’s. 
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Hog cholera can possibly be eradicated from the swine population at an 
economic advantage to the producers. Plans for an eradication program in 
the United States have been formulated and their merits were discussed at 
length in a 1961 symposium edited by Mainwaring & Sorensen (146). 
The	first	means	of	control	for	the	disease	reported	in	1908	(147),	consisted	
of blocking the lethal effect of virulent cholera by the use of a viral antise-
rum simultaneously with the virulent virus. The concept was to elicit immu-
nity following mild clinical infection. Some of the disadvantages of this sys-
tem were overcome by Koprowski et al. (148) and Baker (149) by reducing 
the	virulence	of	the	virus	for	use	in	a	vaccine.	Modification	was	induced	by	
rabbit	 passage.	Vaccines	utilizing	modified	 live	 cholera	 virus	have	been	 in	
general commercial use since 1952, but killed vaccines have not been gener-
ally	accepted	(150).	Viruses	modified	by	passage	in	tissue	culture	have	had	
limited acceptance although excellent claims are made for newer commer-
cial vaccines (151, 152). The use of a bovine enterovirus in a vaccine for hog 
cholera proposed as a possibility by Beckenhauer et al. (153) and Atkinson et 
al. (154), has not been generally accepted. There is good evidence for a sero-
logical relationship between these viruses as indicated by Sheffy et al. (155), 
Gutenkunst	&	Malmquist	 (156),	Mengeling	et	 al.	 (157),	 and	Coggins	&	Seo	
(158), but tissue culture vaccines employing the bovine virus diarrhea agent 
have failed to elicit general protection to hog cholera in vaccinated swine. 
Challenge of pigs vaccinated with the diarrhea agent with some strains of 
virulent	cholera	virus	has	demonstrated	some	protection.	Challenges	utiliz-
ing the standard virulent Ames test virus have not been satisfactory. General 
use of this type of vaccine is thus not probable. 
One problem in the control of hog cholera which must be considered in 
an eradication program is the lack of a rapid and accurate diagnostic test. 
Past diagnoses have relied heavily on history, clinical symptoms, gross and 
microscopic	pathology	because	the	most	definitive	diagnosis	which	involved	
inoculation of both susceptible and immune pigs was both time-consum-
ing and expensive. The criteria for such a diagnosis are described by Dunne 
(159). One serious limitation has been that swine clinically ill with most dis-
eases and especially erysipelas, pseudorabies, Nebraska University disease, 
and edema disease manifest common symptoms. Histopathological lesions 
are	frequently	difficult	to	interpret.	These	limitations	and	emphasis	on	a	chol-
era eradication program, has prompted increased activity in search of satis-
factory diagnostic aids. 
The use of tissue cultures with cytopathogenic effects of virus on cells 
neutralizable	with	 specific	 antiserum	has	 been	 the	 basis	 for	 detection	 and	
identification	of	many	virus	diseases.	Although	Gustafson	&	Pomerat	(160)	
were able to demonstrate the cytopathogenic effects of a laboratory strain 
of	cholera	virus	on	embryonic	swine	tissues,	field	viruses	do	not	generally	
adapt to tissue culture to produce cytopathogenic effects, especially on iso-
lation or early passages. The observation by Lee (161) of nuclear changes 
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in cells of tissue culture systems infected with cholera virus, and the detec-
tion of intranuclear inclusion bodies by Urman et al. (162) in reticuloendo-
thial cells of pigs infected with cholera, serve as aids to the diagnosis of the 
disease. These tests are not simple enough or precise enough to serve as sin-
gle diagnostic tests. The conglutination complement absorption test of Mil-
lian	&	Engelhard	(163)	and	the	hemagglutination	test	of	Segre	(164)	are	quite	
complex and are in need of further evaluation. These tests are better adapted 
to the evaluation of antibodies produced rather than as an indication of vi-
rus in the early acute phases of cholera infection. Evaluation of the agar dif-
fusion precipitation test for cholera diagnosis by McClurkin (165) has indi-
cated that false positives occur in the serum of pigs previously vaccinated 
with crystal violet vaccine. Pirtle (166), in similar studies using pancreatic 
tissues from SPF swine, concluded there was no evidence to relate precipita-
tion	and	hog	cholera	virus.	The	test	described	by	Taylor	(167)	of	utilizing	en-
zymes	from	the	pancreas	of	infected	pigs	to	hydrolyze	starch	has	not	proved	
precise enough for general use. 
Two	relatively	new	tests	which	employ	specific	fluorescein-labeled	glob-
ulins to detect cholera virus show considerable promise as diagnostic tests. 
Immunofluorescence	is	commonly	used	to	refer	to	this	type	of	serological	re-
action.	The	specific	antibodies	for	both	cholera	tests	are	prepared	in	SPF	or	
PFCD pigs as reviewed by McDevitt et al. (168) and can be used to label and 
concentrate	globulins.	The	immunofluorescence	test	used	by	Stair	et	al.	(169)	
identifies	 the	 cholera	viral	 and	 soluble	 antigens	directly	 in	 the	 infected	 tis-
sues	of	swine.	Infection	may	be	detected	as	early	as	the	fifth	day	and	at	least	
through	the	fifteenth	day.	This	test,	based	on	impressions	from	lymph	glands,	
spleen, or kidneys can be set up and read within an hour (170). A similar im-
munofluorescence	test	described	by	Mengeling	et	al.	(171)	detects	antigen	in	
a tissue culture system. Tissue extracts from pigs suspected to have cholera 
are inoculated into the culture system. The test is read 6 to 18 hours later. 
Both tests need further evaluation to determine which is most generally ac-
ceptable for the standard diagnostic laboratory. 
African swine fever — A	test	 related	 in	 significance	 to	 the	hog	cholera	
tests	is	the	hemadsorption	test	developed	by	Malmquist	&	Hay	(172)	for	Af-
rican swine fever. This is a disease of swine in Africa and parts of Europe 
which is immunologically distinct from hog cholera. Since there is no satisfac-
tory vaccine for swine fever, this disease poses a continuous threat to swine 
industries in other parts of the world. The availability of a test which distin-
guishes swine fever from cholera would aid materially in limiting the spread 
of	 the	 former.	 The	development	 of	 an	 immunofluorescence	 test	would	 ap-
pear to be unlikely because of the limited antibody response to swine fever 
virus as reported by DeTray (173). 
Nebraska University disease — The pathogen-free colostrum-deprived 
pig has been useful in identifying infectious entities which would have been 
detected	only	with	difficulty	or	not	at	all	by	the	use	of	conventional	animals	
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and	 techniques.	 A	 good	 example	 is	 Nebraska	 University	 disease	 first	 de-
scribed by Underdahl et al. (174). This is a septicemic disease capable of in-
flicting	heavy	mortality	among	fully	susceptible	swine.	 Immunity	develops	
among surviving swine but the virus persists in carriers. Herd stability to the 
disease is established through colostral immunity among the young pigs at a 
time when they are exposed to the virus, followed by development of active 
immunity.	Infection	may	be	so	modified	by	the	presence	of	antibody	that	the	
disease is inapparent. 
Nebraska	University	disease	was	first	identified	within	a	group	of	adult	
SPF swine which were mingled with a group of conventional swine of sim-
ilar	size.	Members	of	the	conventional	group	appeared	to	be	healthy.	Fight-
ing was severe among members of the two groups as they sought to establish 
a new social order. Within three days, one-third of the SPF group was seri-
ously ill, with animals dying on the third and fourth days. Those which died 
first	were	SPF	pigs	most	severely	lacerated	from	fighting	in	the	new	social	or-
der. None of the conventional pigs died although they sustained lacerations 
as	severe	as	those	of	the	SPF	pigs.	Contact	experiments,	utilizing	PFCD	pigs,	
were	conducted	which	resulted	in	the	isolation	of	a	specific	infectious	filter-
able	and	noncultivatable	entity	recognized	as	the	causative	agent	of	the	Ne-
braska disease. 
Six	months	after	the	introduction	of	the	first	group	of	SPF	pigs	into	the	
herd described above, a second group was introduced. The pathogen-free 
and conventional animals were not placed together in lots but were permit-
ted use of common waterers and feeders with fence contact. Fighting did 
not occur and no illnesses developed in individuals of either group. This 
could have been interpreted as disappearance of the Nebraska agent from 
the	 conventional	 population.	 Serum	 neutralization	 tests	 did	 not	 support	
this view. Tests on paired serum samples from the SPF animals taken pre-
vious to and one month after exposure to the conventional group disclosed 
the	development	 of	 specific	 neutralizing	 antibody	 to	 the	Nebraska	 agent.	
The conclusions drawn were that the agent has moderate virulence and the 
normal	defense	mechanisms	can	adequately	handle	moderate	doses	of	the	
infectious	agent.	The	dosage	inflicted	through	lacerated	skin	during	fight-
ing was large enough to overwhelm the defense systems, permitting fatal 
infection. 
Swine edema disease — An infectious agent associated with edema dis-
ease	of	swine,	also	first	described	by	Underdahl	et	al.	(175,	176),	who	used	
PFCD pigs as experimental hosts, has some similarities to Nebraska Uni-
versity disease. The diseases are immunologically distinct. Both cause clin-
ical illnesses which are similar to each other and to acute swine erysipe-
las or hog cholera. A differential diagnosis therefore becomes of the utmost 
importance. 
There is considerable controversy as to the cause of edema disease in 
swine. Literature reviews by Bennett (177) and Gregory (178) indicate that 
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several investigators attribute the disease to hemolytic strains of Escherichia 
coli. The disease has been attributed to toxins eliminated into the intestines 
by the organisms. The isolation of E. coli from sick animals has not been con-
vincing	evidence,	however,	especially	since	adequately	controlled	transmis-
sion experiments generally have not been conducted which would eliminate 
an associated viral entity. For example, the successful transmission experi-
ments of Gregory (179) resulting in typical edema disease, employed inocula 
from bowel contents which had not been handled to eliminate the presence 
of viruses. The use of conventional pigs as experimental animals also pre-
sented the possibility of activating latent virus by the experimental stresses 
imposed. Coliform bacteria vary in their pathogenicity. Saunders et al. (180) 
demonstrated that some strains lack pathogenicity even for hosts as suscep-
tible as PFCD baby pigs. The most damaging evidence against the E. coli con-
cept of edema disease is presented by Mansson (181). He consistently isolated 
hemolytic E. coli of the serotype associated with edema disease from both sick 
and healthy pigs within a herd over a nine-year period. Since edema disease 
was	not	observed	among	these	pigs,	Mansson	concluded	that	other	prerequi-
sites must enter into this infection. 
The	erratic	occurrence	of	edema	disease	within	swine	herds,	with	afflic-
tion of the best and fastest growing pigs has often been interpreted as death 
due to enterotoxins produced by E. coli. Any explanation involving an infec-
tious viral entity can be as logical. A carrier state is effected with the edema 
agent	 by	modification	of	 the	disease	within	 immune	 animals.	Virus	 is	 car-
ried and shed almost continuously in an infected herd. Newborn pigs are 
protected during the early suckling period through colostral immunity as 
their dams have had previous or continuous exposure to the edema disease 
agent. Since the newborn pig of approximately 2.5 lbs absorbs its protective 
lactoglobulins early and reaches about 25 lbs before it produces appreciable 
amounts of protective gamma globulin of its own, the most rapidly growing 
pigs would have the least relative protection through passive immunity. Ex-
posure to infections in their natural environment would more seriously effect 
the larger and apparently most healthy pigs. The small pigs would possess 
more antibody units per pound of body weight, react to virus subclinically, 
or manifest only mild clinical symptoms and recover. Passive immunity 
would be replaced by active immunity and the animals would have less dif-
ficulty	thriving	in	an	environment	in	which	there	was	repeated	exposure	to	
edema disease. 
Exudative epidermitis of swine — Exudative epidermitis is another dis-
ease of swine which had previously been classed as noninfectious and of un-
known cause. A common farm term is “greasy pig disease” because of the 
brown,	slimy	exudate	which	covers	the	skin.	The	primary	cause,	first	identi-
fied	by	Underdahl	et	al.	(182),	is	a	filterable	virus.	Pathogen-free	colostrum-
deprived	 pigs	 consistently	 develop	mild	 vesicular	 lesions	 from	 filtrates	 of	
naturally infected tissues. The addition of some strains of streptococci or Pro-
teus intensify the infections to produce lesions as severe as those seen in nat-
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ural	field	cases.	Relationship	of	the	bacteria	to	epidermitis	is	in	need	of	fur-
ther evaluation. 
The	 previous	 classification	 of	 exudative	 epidermitis	 as	 noninfectious	
was based on the characteristics of the natural disease. Generally, only a few 
nursing	pigs	 in	 a	 herd	 are	 afflicted.	Littermates	may	 remain	perfectly	nor-
mal. Since experimental epidermitis, through study with several thousand 
PFCD pigs over a 15-year period (85), has been found to be the most infec-
tious disease among these animals, some explanation seems necessary. In 
herds where it has occurred, immunity developed by the sows is transmitted 
to the next generation through colostral milk. In large litters, some pigs are 
crowded away from the dam and fail to get enough colostral milk to protect 
them fully. These pigs develop severe lesions. Since their littermates remain 
normal, the disease has been considered by Wellman (183) to be noninfec-
tious with a heritable or erroneous nutritional cause. The primary causative 
agent may persist in carrier animals within a population for several years. 
The virus remains as a source of infection for new pigs and stimulates some 
degree of immunity among the other animals. 
Foot-and-mouth disease and rinderpest — Foot-and-mouth disease and 
rinderpest are two extremely important diseases of cattle but are not cur-
rently of economic importance in the United States. Since neither disease is 
endemic in our herds, study of these diseases is limited to laboratories out-
side the country. A United States Department of Agriculture laboratory has 
been established on Plum Island, off Long Island, New York, for this type of 
study. Research of both practical (184) and basic nature (185) is being con-
ducted there to obtain information necessary to the control of foot-and-mouth 
disease.	Liaison	is	maintained	with	Canadian	officials	for	the	use	of	special	is-
land laboratory facilities for challenge of United States cattle recovered from 
diseases with rinderpest-like symptoms. Thus far, suspects have had bovine 
virus diarrhea and were fully susceptible to virulent rinderpest virus. A con-
tinual vigilance must be maintained, however, as a safeguard against the es-
tablishment and spread of exotic cattle disease. 
Disease Control
One of the obstacles to the control of viral infections of domestic animals 
has been the ideology that disease is inevitable. Animals, under this philos-
ophy, must live with diseases and become adapted to them. “Control” is ef-
fected	by	modification	of	disease	by	changes	in	diet,	changes	in	environment,	
and retention of breeding animals best able to survive and thrive under the 
conditions imposed. The “live with” philosophy includes the use of drugs 
such as antibiotics, sulfonamides, and arsenicals in animal feeds, and as med-
icants.	Vaccines	are	also	utilized	for	those	diseases	to	which	antibody	can	be	
developed in response to injection of antigens to supplement or better gov-
ern disease as it occurs in nature. Many of these vaccines are directed at the 
control of bacterial infections which would effect viral infections in a second-
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ary way. This would also seem to be the role played by the drugs fed as ad-
ditives since they are not generally effective against the multitude of viruses 
which plague animal populations. 
Developments in animal production in recent years have used an old, 
old concept of isolation to control animal disease. Lancisi, as interpreted 
by Fleming (186), in the early 1700’s expressed his belief that the virus of 
foot-and-mouth disease gained access to the body by the air passages and 
stomach. His concept of control was by isolation inasmuch as cattle in mon-
asteries escaped the contagion even when located in the center of the plague-
haunted districts. He attributed the absence of disease to “cattle having no 
communication whatever with those beyond the high walls enclosing their 
pastures.” 
It	 is	recognized	that	the	problems	of	controlling	human	diseases	by	iso-
lation is incompatible with the process of living, and, as expressed by Du-
bos (187) relating to man, “ Disease will remain an inescapable manifestation 
of his struggles.” In some disagreement with Dubos, it is known that practi-
cal control of many virus diseases of animals can be accomplished through 
isolation.	Man’s	 animals	may	 be	 freed	 of	 specific	 virus	 diseases	 then	 need	
not have direct communication with other groups, as does man in his social 
order. Should a breakdown in isolation occur; permitting the animals to be-
come infected, the virus may again be eliminated and a new disease-free pop-
ulations formed. 
The key to the successful control of virus diseases of animals by isolation 
has been the ability to prevent the exposure of the newborn animal to trou-
blesome viruses in its dam’s environment. The fetus is delivered aseptically 
by surgery near term. It may then be raised in an isolated environment as 
a	PFCD	animal	with	gradual	 conversion	 to	 a	 specific	pathogen-free	 status.	
Practical isolation procedures, both for repopulation and research purposes 
as described by Young & Underdahl (188, 189), Young et al. (190), and Un-
derdahl & Young (191, 192), have been adapted by other laboratories. The 
extended use of these methods for the production of SPF pigs by others has 
been reviewed by Young (193). 
In repopulation for practical livestock production, animals raised in lab-
oratory isolation are eventually placed on farms from which other livestock 
have been removed. The new stock is reproduced by natural birth for suc-
ceeding generations but without contact with animals of the same species 
which have not had similar origin. This procedure has been successfully used 
in the development of a multi-thousand population of SPF pigs in a practi-
cal on-the-farm disease control program [See Caldwell (194) ; Caldwell et al. 
(195, 196, 197) ; Underdahl et al. (198) ; Welch (199) ; and Young et al. (200, 
201)], which has been especially useful in the elimination of atrophic rhinitis 
and virus pneumonia. 
Similar programs have been established in other areas of the United 
States. Controlled studies on swine repopulation in Canada using SPF ani-
mals have been reported by Abelseth et al. (202), with promising results for 
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the control of rhinitis and virus pneumonia. Studies in England by Betts et 
at. (203) are primarily directed toward control of the latter disease. National 
standards	 for	 minimal-disease	 pigs,	 equivalent	 to	 American	 SPF,	 have	 re-
cently been established by the Pig Industry Development Authority (204). 
The principles successfully applied to swine repopulation basically have 
potential usefulness for the eradication or control of many diseases of domes-
tic animals. The primary problem would appear to be to justify effort and 
cost in relation to the value of the stock involved and the importance of elim-
inating a given disease or group of diseases. 
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